Top Stocks today: Nvidia, Robinhood and Pfizer lead the market

TheStreetTuesday, September 30, 2025 at 11:41:57 PM
Top Stocks today: Nvidia, Robinhood and Pfizer lead the market
Today, the stock market saw significant movements with Nvidia, Robinhood, and Pfizer leading the charge. This is noteworthy as it reflects investor confidence and market trends, which can influence future investments and economic stability.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Gambling Apps Meet Their Match As Cheaper, Regulated Prediction Markets Foray Into Sports, Cultural Events
NegativeFinancial Markets
Gambling apps like DraftKings and FanDuel are facing tough competition as new players like Kalshi and Robinhood enter the prediction market space. These companies are offering cheaper and regulated options for betting on sports and cultural events, which could significantly impact the traditional gambling industry. This shift is important because it highlights a growing trend towards more accessible and regulated betting options, potentially changing how consumers engage with these markets.
Explainer-What does Trump's deal with Pfizer mean for drug prices?
NeutralFinancial Markets
The recent deal between Trump and Pfizer has sparked discussions about its potential impact on drug prices in the U.S. This agreement aims to lower costs for consumers, which is a significant concern for many Americans facing high healthcare expenses. Understanding the details of this deal is crucial as it could set a precedent for future pharmaceutical policies and influence how drug pricing is approached moving forward.
Pfizer to offer cheaper drugs via Trump's website
PositiveFinancial Markets
Pfizer has announced that it will offer significant discounts on some of its medications, with prices slashed by up to 85% through the TrumpRx website. This move is expected to make essential drugs more accessible to consumers, highlighting a shift towards more affordable healthcare options. It matters because it could alleviate financial burdens for many patients and spark discussions about drug pricing in the industry.
Pfizer does deal with Trump on prescription drug prices
PositiveFinancial Markets
Pfizer has reached a significant agreement with former President Trump aimed at lowering prescription drug prices. This deal is crucial as it addresses the ongoing concerns about the affordability of medications for millions of Americans. By collaborating with a high-profile figure like Trump, Pfizer is not only taking steps to enhance its public image but also showing a commitment to making healthcare more accessible, which could have a lasting impact on patients and the healthcare system.
US drugmakers rise after Trump announces Pfizer price cuts
PositiveFinancial Markets
US drugmakers saw a surge in stock prices following President Trump's announcement of price cuts for Pfizer medications. This move is significant as it reflects the administration's ongoing efforts to make healthcare more affordable for Americans. The price reductions could lead to increased access to essential medications, benefiting millions of patients and potentially reshaping the pharmaceutical landscape.
Stocks Post Late Rally After Trump Strikes Deal With Pfizer
PositiveFinancial Markets
In a surprising turn of events, stocks rallied late in the trading session following former President Trump's deal with Pfizer. This boost in pharmaceutical stocks helped lift market indexes, providing a glimmer of hope amidst concerns about a potential government shutdown. Investors are optimistic that this deal could signal stability in the healthcare sector, making it a significant development for the market.
Trump Announces Pfizer Deal to Lower Some Drug Prices and Unveils TrumpRx Website
PositiveFinancial Markets
President Trump has announced a new initiative aimed at lowering drug prices through a deal with Pfizer, alongside the launch of the TrumpRx website. This platform will enable consumers to purchase medications directly from manufacturers, potentially saving them money and increasing access to essential drugs. This move is significant as it addresses ongoing concerns about high prescription costs and aims to empower consumers in their healthcare choices.
SEC plan for blockchain-based stocks pits Coinbase and Robinhood against Wall Street giants
PositiveFinancial Markets
The SEC's plan to allow blockchain-based stocks is shaking up the financial landscape, positioning companies like Coinbase and Robinhood against traditional Wall Street giants. This move is significant as it opens the door for tokenized stocks, which are already being offered in Europe and other regions, potentially transforming how investors engage with the stock market.
Pfizer strikes $70B deal with Trump to cut Medicaid drug prices, expand American manufacturing under tariff threat
PositiveFinancial Markets
Pfizer has announced a significant $70 billion deal with President Trump aimed at reducing Medicaid drug prices and boosting American manufacturing. This move is crucial as it not only addresses the rising costs of medications for millions of Americans but also strengthens domestic production in the face of tariff threats. Trump's endorsement highlights the importance of this agreement, signaling a commitment to improving healthcare affordability and supporting local jobs.
Pfizer agrees to offer discounted drugs through new federal website, Trump announces
PositiveFinancial Markets
In a significant move for healthcare accessibility, President Donald Trump announced that Pfizer will offer discounted medications through a new federal website. This initiative aims to provide medications to Medicaid at 'most favored nation' pricing, ensuring that patients can access essential drugs at lower costs. This development is crucial as it addresses the ongoing concerns about high prescription drug prices and aims to improve healthcare affordability for millions of Americans.
Pfizer stock gains as BMO reiterates Outperform rating amid Trump deal
PositiveFinancial Markets
Pfizer's stock has seen a notable increase following BMO's decision to reiterate its Outperform rating, particularly in light of a recent deal involving former President Trump. This development is significant as it reflects investor confidence in Pfizer's future performance and the potential impact of political events on the pharmaceutical industry.
Trump Announces ‘TrumpRx’ Website Offering Discounted Prescription Drugs
PositiveFinancial Markets
Former President Trump has launched a new website called 'TrumpRx' aimed at providing discounted prescription drugs, including those manufactured by Pfizer. This initiative is significant as it seeks to alleviate the financial burden of medication costs for many Americans, especially in a time when healthcare affordability is a pressing issue. By offering these discounts, TrumpRx could potentially improve access to essential medications for those in need.
Latest from Financial Markets
HSBC upgrades Page Industries stock rating to Hold on valuation correction
PositiveFinancial Markets
HSBC has upgraded its rating for Page Industries' stock to 'Hold', indicating a positive outlook based on recent valuation corrections. This move is significant as it reflects confidence in the company's financial health and market position, suggesting that investors may find stability in holding onto their shares rather than selling. Such upgrades can influence market sentiment and attract more investors, potentially leading to a more robust stock performance in the future.
Asian factories struggle as soft China, US demand takes toll
NegativeFinancial Markets
Asian factories are facing significant challenges as demand from both China and the US softens, leading to a slowdown in production and economic uncertainty. This situation is crucial as it highlights the interconnectedness of global supply chains and the potential ripple effects on economies worldwide. As these factories struggle, it raises concerns about job security and economic stability in the region.
‘The Simpsons' Movie Sequel Could Be Disney’s Smartest Sequel Yet
PositiveFinancial Markets
Disney's decision to bring 'The Simpsons' back to theaters in 2027 is generating excitement, as it could be one of the smartest moves in the evolving landscape of legacy franchises. With the show's enduring popularity and cultural impact, this sequel has the potential to attract both longtime fans and new audiences, making it a significant addition to Disney's lineup.
Indonesia Wealth Fund CIO on Investment Strategies
PositiveFinancial Markets
Pandu Sjahrir, the Chief Investment Officer of Indonesia's sovereign wealth fund Danantara, recently shared insights on investment opportunities during a conversation with Haslinda Amin at the Milken Institute Asia Summit in Singapore. This discussion is significant as it highlights Indonesia's strategic approach to attracting investments, which could bolster the country's economic growth and enhance its global financial standing.
Danantara CIO says Freeport Divestment Unlikely to Be Free
NeutralFinancial Markets
The chief investment officer of Indonesia's Danantara sovereign wealth fund has indicated that the divestment of additional shares by Freeport-McMoRan Inc. in its local unit is nearly complete. This development is significant as it highlights ongoing negotiations between the Indonesian government and the US mining giant, reflecting the country's efforts to increase local ownership in key industries.
Paris Fashion Week: All Done Up For Work, All The Time
NeutralFinancial Markets
Paris Fashion Week S/S 2026 showcased a strong message about preparing for the challenges of work life, emphasizing the need for resilience. While the overall theme suggested a tough journey ahead, the event also highlighted the unique flair of Paris, reminding us that even in difficult times, creativity and style can shine through.